Pfizer, Inc. — PFE
| Close Price | Market Cap | P/E Ratio | Forward P/E Ratio | Implied Growth* | Implied Forward Growth* | Dividend | P/B Ratio |
|---|---|---|---|---|---|---|---|
| $27.19 | $154.67B | 20.0 | 9.7 | 11.5% | 4.0% | $1.72 6.3% | 1.8 |
Latest Headlines
- · A Fund Just Bet $5.7 Million on Robert Half -- Is the Staffing Sector Due for a Rebound?
- · What to Look for Before Buying a Pharma Stock
- · QSM Asset Management Bets on Beaten-Down Manpower Group With New $5.9 Million Stake in ManpowerGroup
- · Pfizer's Non-Oncology Portfolio in Focus Ahead of Q1 Earnings
- · UBS Adjusts Pharma Outlook, Increases Pfizer (PFE) Price Target
- · Telix Expands Board As Valuation And Momentum Draw Investor Attention
Revenue & Net Income
| Date | Revenue | Net_Income | EPS | Last_Updated | Revenue_Change | Net_Income_Change | EPS_Change | |
|---|---|---|---|---|---|---|---|---|
| 0 | 2020-12-31 | $41,651M | $9,159M | $1.73 | 2024-02-03 03:17:10 | N/A | N/A | N/A |
| 1 | 2021-12-31 | $81,288M | $21,979M | $3.92 | 2026-03-05 08:40:09 | 95.2% | 140.0% | 126.6% |
| 2 | 2022-12-31 | $101,175M | $31,372M | $5.59 | 2026-04-15 21:58:55 | 24.5% | 42.7% | 42.6% |
| 3 | 2023-12-31 | $59,554M | $2,119M | $0.38 | 2026-04-15 21:58:55 | -41.1% | -93.2% | -93.2% |
| 4 | 2024-12-31 | $63,627M | $8,031M | $1.42 | 2026-04-15 21:58:55 | 6.8% | 279.0% | 273.7% |
| 5 | 2025-12-31 | $62,579M | $7,771M | $1.37 | 2026-04-15 21:58:55 | -1.6% | -3.2% | -3.5% |
| 6 | TTM 2025-12-31 | $62,579M | $7,770M | $1.36 | 2026-02-05 08:33:21 | 0.0% | -0.0% | -0.7% |
EPS
Forecasts
Y/Y % Change
PFE Year-over-Year Growth
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | Average | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue Growth (%) | 95.2% | 24.5% | -41.1% | 6.8% | -1.6% | -2.4% | -3.6% | 11.1% | |
| Revenue Analysts (#) | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 5 | |
| EPS Growth (%) | 140.0% | 42.7% | -93.2% | 279.0% | -3.2% | 118.1% | -5.4% | 68.3% | |
| EPS Analysts (#) | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 7 |
Expenses
| Year | Revenue ($) | Cost of Revenue ($) | R&D ($) | SG&A ($) | Facilities / D&A ($) |
|---|---|---|---|---|---|
| 2022 | $101.2B | $27.8B | $11.4B | $13.7B | $5.1B |
| 2023 | $59.6B | $17.1B | $10.7B | $14.8B | $6.3B |
| 2024 | $63.6B | $9.1B | $10.8B | $14.7B | $7.0B |
| 2025 | $62.6B | $7.8B | $10.4B | $13.8B | $6.6B |
| TTM | $62.6B | $7.8B | $10.4B | $13.8B | $6.6B |
| Year | Revenue Change (%) | Cost of Revenue Change (%) | R&D Change (%) | SG&A Change (%) | Facilities / D&A Change (%) |
|---|---|---|---|---|---|
| 2023 | -41.14 | -38.52 | -6.55 | 8.00 | 24.21 |
| 2024 | 6.84 | -46.74 | 1.34 | -0.28 | 11.49 |
| 2025 | -1.65 | -14.86 | -3.56 | -6.35 | -6.00 |
| TTM | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
No unmapped expenses.
Balance Sheet
| Metric | Value | |
|---|---|---|
| 0 | Total Assets | $208,731M |
| 1 | Cash | $1,343M |
| 2 | Total Liabilities | $115,635M |
| 3 | Total Debt | $60,848M |
| 4 | Total Equity | $92,801M |
| 5 | Debt to Equity Ratio | 0.66 |
EPS & Dividend
Valuation
| Share Price | Treasury Yield | Estimates | Fair Value (P/E) | Fair Value (P/S) | Current P/S | Current P/E |
|---|---|---|---|---|---|---|
| $27.19 | 4.3% | Nicks Growth: 2% Nick's Expected Margin: 10% FINVIZ Growth: -9% |
Nicks: 8 Finviz: 2 |
Nick's: 0.794 | 2.5 | 20.0 |
| Basis | Year | Nicks Valuation | Nicks vs Share Price | Finviz Valuation | Finviz vs Share Price |
|---|---|---|---|---|---|
| $1.36 EPS | TTM | $10.80 | -60.3% | $3.23 | -88.1% |
| $2.98 EPS | 2026 | $23.66 | -13.0% | $7.08 | -73.9% |
| $2.82 EPS | 2027 | $22.39 | -17.7% | $6.70 | -75.3% |
Implied Growth
| Average | Median | Std Dev | Current | Percentile | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| TTM | Forward | TTM | Forward | TTM | Forward | TTM | Forward | TTM | Forward | |
| Timeframe | ||||||||||
| 1 Year | 8.81% | 2.85% | 8.13% | 2.70% | 1.87% | 0.62% | 11.40% | 3.91% | 90.5% | 91.4% |
| 3 Years | 8.81% | 2.85% | 8.13% | 2.70% | 1.87% | 0.62% | 11.40% | 3.91% | 90.5% | 91.4% |
| 5 Years | 8.81% | 2.85% | 8.13% | 2.70% | 1.87% | 0.62% | 11.40% | 3.91% | 90.5% | 91.4% |
| 10 Years | 8.81% | 2.85% | 8.13% | 2.70% | 1.87% | 0.62% | 11.40% | 3.91% | 90.5% | 91.4% |